NAMPT and LYST as potential therapeutic targets in multiple myeloma
Multiple myeloma (MM) is a type of blood cancer that affects the plasma cell. It is a rare form of cancer, accounting for 1% of all cancer diagnoses and 2% of all cancer deaths. The […]